From: Arizona Daily Star
Tucson-based drug startup NuvOx Pharma has been awarded a $1 million grant from the National Cancer Institute to continue its research on treatment for glioblastoma, a deadly form of brain cancer.
Read More: Tucson-based NuvOx wins $1M cancer grant